Peter Wohrle
Oral and Maxillofacial Surgery · Newport Beach, CANPI 1871519033
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $550,000 of the $735,460 with a category attached, or 74.8%. Nobel Biocare USA accounts for 96.1% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $694,114 and has fallen 99.4% since, to $4,430 in 2024. Among oral and maxillofacial surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 34 payments — averaging $21,631 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nobel Biocare USA$706K
- Keystone Dental Inc.$29K
- Kerr Corporation$230
- Implant Direct Sybron International LLC$92
What the payments were for
- Royalty or licence$550,00075%
- Consulting fees$12,0002%
- Speaking & faculty fees$147,00020%
- Travel & lodging$24,6873%
- Food & beverage$1,3960%
- Entertainment$3770%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nobel Biocare USA | 22 | $706,464 |
| Keystone Dental Inc. | 9 | $28,674 |
| Kerr Corporation | 2 | $230 |
| Implant Direct Sybron International LLC | 1 | $92 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NOBELACTIVE$706,114
- NOBELPARALLEL$706,114
- NOBELSPEEDY$702,114
- NOBELREPLACE$702,114
- NOBELPROCERA$702,114
How this compares
$735,460 in reported general payments places this provider in the 95th percentile of 941 oral and maxillofacial surgery providers in California.
See all oral and maxillofacial surgery providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 13 | $74 |
| Chlorhexidine Gluconate | 17 | $20 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Newport Beach
- Edmond BedrossianSan Francisco$3.7M
- Jone KimBrea$721K
- G William ArnettSanta Barbara$713K
- Arshiya SharafiSan Diego$457K
- Alan HerfordColton$292K
- Robert HaleWoodland Hills$230K
- Tara AghalooLos Angeles$214K
- Daniel HammerSan Diego$201K
- Nader SalibMission Viejo$189K
- Peter MoyLos Angeles$175K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.